• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday

    4/4/24 10:44:23 AM ET
    $ALPN
    $AQST
    $FNA
    $HIMS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALPN alert in real time by email

    U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday.

    Shares of Lamb Weston Holdings, Inc. (NYSE:LW) fell sharply during Thursday’s session after the company reported weak third-quarter results and cut its FY24 outlook.

    Lamb Weston posted adjusted earnings of $1.20 per share, missing market estimates of $1.45 per share. The company’s quarterly sales came in at $1.46 billion versus expectations of $1.65 billion, according to data from Benzinga Pro.

    Lamb Weston shares tumbled 17.5% to $83.40 on Thursday.

    Here are some other big stocks recording losses in today’s session.

    • DigiAsia Corp. (NASDAQ:FAAS) shares dipped 20% to $5.37.
    • GCT Semiconductor Holding, Inc. (NYSE:GCTS) dipped 13.1% to $5.96.
    • SolarMax Technology, Inc. (NASDAQ:SMXT) declined 10.9% to $11.75.
    • Paragon 28, Inc. (NYSE:FNA) fell 10.4% to $10.80. Paragon 28 announced CFO Transition and issued preliminary unaudited net revenue for the first quarter.
    • Resources Connection, Inc. (NASDAQ:RGP) dipped 9.2% to $11.15 following weak quarterly sales.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) declined 8.9% to $3.9850 after the company filed for an up to $250 million mixed shelf offering.
    • Rent the Runway, Inc. (NASDAQ:RENT) declined 8.6% to $5.37.
    • Paramount Global (NASDAQ:PARA) dipped 8.2% to $12.40 following a report suggesting the Ellison-led bid would require the company to raise new equity.
    • Hims & Hers Health, Inc. (NASDAQ:HIMS) fell 4.9% to $14.76.
    • Hertz Global Holdings, Inc. (NASDAQ:HTZ) fell 4% to $7.32 after Goldman Sachs downgraded the stock from Neutral to Sell and lowered its price target from $8 to $7.
    • Alpine Immune Sciences, Inc. (NASDAQ:ALPN) fell 3.6% to $36.73.

     

    Now Read This: Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000

    Get the next $ALPN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALPN
    $AQST
    $FNA
    $HIMS

    CompanyDatePrice TargetRatingAnalyst
    Hims & Hers Health Inc.
    $HIMS
    2/24/2026Buy → Neutral
    BTIG Research
    Hims & Hers Health Inc.
    $HIMS
    1/12/2026$33.00In-line
    Evercore ISI
    Lamb Weston Holdings Inc.
    $LW
    12/22/2025Outperform → Neutral
    BNP Paribas Exane
    Hims & Hers Health Inc.
    $HIMS
    12/9/2025$48.00Overweight
    Barclays
    Hims & Hers Health Inc.
    $HIMS
    10/21/2025Sector Weight
    KeyBanc Capital Markets
    Resources Connection Inc.
    $RGP
    9/24/2025$7.00Buy
    Northcoast
    Lamb Weston Holdings Inc.
    $LW
    8/20/2025$57.00Neutral
    Analyst
    Paramount Global
    $PARA
    7/28/2025$11.00Neutral → Sell
    Seaport Research Partners
    More analyst ratings

    $ALPN
    $AQST
    $FNA
    $HIMS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rent the Runway, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Rent the Runway, Inc. ("Rent the Runway") (NASDAQ:RENT) announced today the grant of an inducement award to Dhiren Fonseca, the Executive Chair of Rent the Runway's Board of Directors, effective February 27, 2026.  The inducement award is comprised of 802,395 restricted stock units in respect of Rent the Runway's Class A common stock ("RSUs"). The RSUs will vest as to 25% of the shares underlying the RSUs on October 28, 2026, with the remaining 75% of the RSUs vesting in equal quarterly installments through October 28, 2029, subject to continued service through the applicable vesting date. The inducement award was unanimously approved by Rent t

    2/27/26 9:00:00 AM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    RGP to Participate in Truist Securities' Inaugural Human Capital Virtual Conference

    RGP (NASDAQ:RGP), a global professional services firm, today announced that Chief Executive Officer Roger Carlile and Chief Financial Officer Jenn Ryu will participate in Truist Securities' inaugural Human Capital Virtual Conference on Thursday, March 12, 2026. Management will host virtual investor meetings throughout the day. For additional information or to request a meeting, please contact your Truist sales representative. About RGP RGP (NASDAQ:RGP) has been redefining professional services for 30 years by closing the gap between advice and execution. RGP combines the flexibility of on-demand talent, the rigor of consulting, and the accountability of managed services for faster impac

    2/25/26 6:30:00 PM ET
    $RGP
    Real Estate

    Aquestive Therapeutics to Participate in Upcoming March Investor Conferences

    WARREN, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participate in four upcoming investor conferences in March as follows: TD Cowen 46th Annual Health Care Conference: Management will be available for 1x1 meetings on Tuesday, March 3rdLeerink Partners Global Healthcare Conference 2026: fireside chat to take place on Monday, March 9th at 10:40am ET; management will also be available for 1x1 meetingsCitizens Life Sciences Confer

    2/25/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALPN
    $AQST
    $FNA
    $HIMS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chair Craps Jan Eli B bought $2,432,330 worth of shares (50,000 units at $48.65) and was granted 317,647 shares, increasing direct ownership by 147% to 617,647 units (SEC Form 4)

    4 - Lamb Weston Holdings, Inc. (0001679273) (Issuer)

    2/6/26 5:10:07 PM ET
    $LW
    Packaged Foods
    Consumer Staples

    Director Cg Core Value Fund, L.P. bought $452,100 worth of shares (100,000 units at $4.52) (SEC Form 4)

    4 - RESOURCES CONNECTION, INC. (0001084765) (Issuer)

    11/13/25 4:28:22 PM ET
    $RGP
    Real Estate

    Director Fox Jeffrey H bought $452,100 worth of shares (100,000 units at $4.52) (SEC Form 4)

    4 - RESOURCES CONNECTION, INC. (0001084765) (Issuer)

    11/13/25 4:04:29 PM ET
    $RGP
    Real Estate

    $ALPN
    $AQST
    $FNA
    $HIMS
    SEC Filings

    View All

    SEC Form S-8 filed by Rent the Runway Inc.

    S-8 - Rent the Runway, Inc. (0001468327) (Filer)

    2/27/26 8:30:10 AM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    Hertz Global Holdings Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HERTZ GLOBAL HOLDINGS, INC (0001657853) (Filer)

    2/26/26 8:23:33 AM ET
    $HTZ
    Rental/Leasing Companies
    Consumer Discretionary

    SEC Form 10-K filed by Hertz Global Holdings Inc

    10-K - HERTZ GLOBAL HOLDINGS, INC (0001657853) (Filer)

    2/26/26 8:20:31 AM ET
    $HTZ
    Rental/Leasing Companies
    Consumer Discretionary

    $ALPN
    $AQST
    $FNA
    $HIMS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALPN
    $AQST
    $FNA
    $HIMS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hims & Hers Health downgraded by BTIG Research

    BTIG Research downgraded Hims & Hers Health from Buy to Neutral

    2/24/26 7:59:48 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Evercore ISI initiated coverage on Hims & Hers Health with a new price target

    Evercore ISI initiated coverage of Hims & Hers Health with a rating of In-line and set a new price target of $33.00

    1/12/26 8:13:43 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Lamb Weston downgraded by BNP Paribas Exane

    BNP Paribas Exane downgraded Lamb Weston from Outperform to Neutral

    12/22/25 11:24:00 AM ET
    $LW
    Packaged Foods
    Consumer Staples

    $ALPN
    $AQST
    $FNA
    $HIMS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Boughton Soleil was granted 273,794 shares, increasing direct ownership by 159% to 445,623 units (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    2/25/26 4:16:33 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Okupe Oluyemi was granted 410,690 shares, increasing direct ownership by 448% to 502,307 units (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    2/25/26 4:16:40 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Chief Operating Officer Chi Michael was granted 365,058 shares, increasing direct ownership by 120% to 670,219 units (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    2/25/26 4:16:27 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $ALPN
    $AQST
    $FNA
    $HIMS
    Leadership Updates

    Live Leadership Updates

    View All

    Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

    Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company's ability to bring access to high-quality, personalized care to more people across the world. As its US business continues to grow, Hims & Hers will be well-positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. The terms of the transaction have been structu

    2/19/26 6:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

    Board-certified allergist and leading food allergy and anaphylaxis researcher joins Aquestive to support Anaphylm™ (dibutepinephrine) sublingual film NDA resubmission and pipeline WARREN, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Matthew Greenhawt, MD, MBA, MSc, as Chief Medical Officer, strengthening its leadership team as the Company prepares to resubmit its Anaphylm™ New Drug Application (NDA) to the United Stated Food and Drug Admi

    2/18/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy

    Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Deb Autor as the company's first Chief Policy Officer. In this new role, Autor will collaborate with other stakeholders, including consumers, telehealth platforms, providers, advocacy groups, medical associations, pharmaceutical companies, medtech innovators, policymakers, and regulators, with the goal of paving the way to the healthcare of the future - where the power of technology will be combined with the best of personalized care. She will lead the company's global public policy, regulatory, and government affairs functions. A former senior leader at the FDA, prosecutor f

    11/17/25 6:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $ALPN
    $AQST
    $FNA
    $HIMS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Rent the Runway Inc.

    SC 13G/A - Rent the Runway, Inc. (0001468327) (Subject)

    11/14/24 5:08:56 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Aquestive Therapeutics Inc.

    SC 13G/A - Aquestive Therapeutics, Inc. (0001398733) (Subject)

    11/14/24 3:47:19 PM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Resources Connection Inc.

    SC 13G/A - RESOURCES CONNECTION, INC. (0001084765) (Subject)

    11/12/24 5:01:11 PM ET
    $RGP
    Real Estate

    $ALPN
    $AQST
    $FNA
    $HIMS
    Financials

    Live finance-specific insights

    View All

    Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET

    WARREN, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the fourth quarter ended December 31, 2025 and provide an update on recent developments in its business after market close on Wednesday, March 4, 2026. Management will host a conference call for investors at 8:00 a.m. ET on Thursday, March 5, 2026. To participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webc

    2/24/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    Revenue of approximately $2.35 billion, up 59% year-over-year in 2025 Net income of $128 million; Adjusted EBITDA of $318 million in 2025 Subscribers grew to over 2.5 million, up 13% year-over-year in 2025 Provides Q1 and full year 2026 guidance1, with full year 2026 revenue in the range of $2.7 billion to $2.9 billion and Adjusted EBITDA in the range of $300 million to $375 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2025 in a shareholder letter that is posted at investors.hims.com. "More than 2.5 million subscribe

    2/23/26 4:05:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Lamb Weston Announces Leadership Changes to Accelerate Focus to Win Strategy and Drive Shareholder Value

    Jan Craps Brings Global Experience to the Newly Created Executive Chair Role; James D. Gray Appointed Chief Financial Officer Lamb Weston Holdings, Inc. (NYSE:LW) announced today two leadership appointments intended to accelerate growth and drive long-term shareholder value. Jan Craps Appointed Executive Chair The Lamb Weston board of directors has appointed Jan Craps executive chair, effective February 6, 2026. Jan brings deep international experience to the newly created role, including more than 20 years with Anheuser-Busch InBev, most recently as the CEO and Co-Chair of Budweiser Brewing Company APAC, and CEO APAC for Anheuser-Busch InBev. Jan has shaped emerging and complex marke

    2/4/26 9:00:00 AM ET
    $LW
    Packaged Foods
    Consumer Staples